[
pfizer inc
]
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants: Study
By Reuters | Posted by Prashasti Singh | New York
UPDATED ON JAN 08, 2021 09:07 AM IST
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
‘2 vaccines a result proactive approach,’ says DG-ICMR
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 04, 2021 05:48 AM IST
“These kinds of approvals are purely data-driven, and in both these vaccines Phase 2 immunogenicity has been well established. The question of approving a vaccine without adequate data does not arise as the expert panel minutely scans the national as well international data presented to them before granting an approval,” said DG-ICMR.
Covid-19 vaccination: Singapore, Ireland commence immunisation drives
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 30, 2020 10:30 AM IST
Iran has started its first study of the safety and effectiveness of a Covid-19 vaccine, a locally developed candidate.
Covid-19 vaccine update: Gennova Pharmaceuticals gets permission for trials, US deems Moderna candidate safe for use
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 16, 2020 07:48 AM IST
Oman has joined the list of countries to allow the use of Pfizer’s vaccine candidate. Indonesia, meanwhile, is planning to vaccinate its young people before senior citizens.
Covid-19 vaccine update: US begins vaccination drive, Russia claims its Sputnik V over 91% effective
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 15, 2020 07:47 AM IST
Israel’s defence ministry has said the Israel Institute for Biological Research (IIBR) has “successfully completed” phase one of the domestic Covid-19 vaccine trials and plans to start phase two “in the coming days.”
Canada expects first Pfizer/BioNTEch Covid-19 vaccines to arrive Sunday
By Reuters | Posted by Kunal Gaurav | Ottawa
PUBLISHED ON DEC 13, 2020 10:58 PM IST
As early as Monday, Canada and the United States are set to become the first Western nations after the UK to begin inoculations with the vaccine developed by Pfizer Inc and Germany’s BioNTech SE.
US has authorized the first Covid-19 vaccine. What happens next?
By hindustantimes.com| Edited by Mallika Soni | Hindustan Times, New Delhi
PUBLISHED ON DEC 12, 2020 10:15 AM IST
The federal government plans to release the nation’s first 2.9 million doses within days of the authorization to 64 states, US territories and major cities, as well as five federal agencies.
US FDA nod may give Pfizer’s approval case in India a boost
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON DEC 12, 2020 07:32 AM IST
So far, the Indian regulator has not granted regulatory approvals to any vaccine candidate based on data generated during trials held in other countries.
Where are we in the Covid-19 vaccine race?
By Reuters | Posted by Shivani Kumar | Reuters
UPDATED ON DEC 11, 2020 09:16 PM IST
The coronavirus pandemic has killed as many as 1.6 million people worldwide.
Mobile technology will aid India’s Covid vaccination drive, says PM Modi
By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON DEC 08, 2020 12:33 PM IST
PM Modi urged the younger generation to keep innovating and also highlighted the crucial role technology played in the handling of the coronavirus pandemic.
India speeding up review of Pfizer, Astra Covid-19 vaccines: Official
By Reuters | Posted by Shivani Kumar | New Delhi
UPDATED ON DEC 07, 2020 11:11 PM IST
The Indian government is pinning its hopes for mass supply of the vaccine on Serum Institute of India, the world’s largest vaccine producer by volume, which on Monday lodged the first formal application for emergency use approval for AstraZeneca Plc’s Covid-19 vaccine.
US to prepare for swift vaccine roll out as Covid cases surge
By Reuters | Posted by Nilavro Ghosh | Washington
UPDATED ON DEC 02, 2020 07:15 AM IST
Some 60 million to 70 million doses of Covid-19 vaccine could be available per month beginning in January, after the expected regulatory approval of products from Pfizer Inc and Moderna Inc.
Pfizer-BioNTech apply for EU emergency authorization for Covid-19 vaccine
By Reuters | Posted by Kunal Gaurav | Frankfurt
PUBLISHED ON DEC 01, 2020 03:51 PM IST
The application to the European Medicines Agency (EMA) comes after the companies applied for US approval on Nov. 20, taking them a step closer to launching their vaccine.
Moderna files for US vaccine authorization, will seek EU nod
By Reuters | Posted by Prashasti Singh
UPDATED ON DEC 01, 2020 06:46 AM IST
A shot developed by Pfizer Inc and BioNTech SE that was 95% effective in its pivotal trial is set to be reviewed by a panel of outside experts a week earlier. The FDA will decide on the emergency use authorizations (EUA)after the advisers make their recommendations.
Covid-19 vaccine updates: UK to purchase over 350 mn doses, US likely to see vaccine roll out before Dec end
By hindustantimes.com| Edited by: Harshit Sabarwal | Hindustan Times, New Delhi
UPDATED ON NOV 30, 2020 08:25 AM IST
The UK is poised to become the first country to approve the vaccine developed by Pfizer Inc and BioNTech SE. The government had already indicated that it would move fast on any promising vaccine candidate and British doctors have been put on standby for a possible roll out before Christmas
Explained: When and how will Covid-19 vaccines become available around the world?
By Reuters | Posted by Niyati Singh | New York
UPDATED ON NOV 25, 2020 08:20 PM IST
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their Covid-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90% effective.
Covid-19 vaccine update: India to immunise 250 million citizens, US vaccinations might begin in December
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON NOV 23, 2020 01:42 PM IST
The United Kingdom could give approval to Pfizer’s vaccine candidate this week, a report claimed. Meanwhile, the official Twitter account of Russia’s vaccine candidate Sputnik V claimed the price per dose of the vaccine would be “much lower” than that of Moderna and Pfizer’s vaccine candidates.
Pfizer Covid-19 vaccine could get UK approval this week: Report
By Reuters | Posted by Shivani Kumar | London
UPDATED ON NOV 23, 2020 02:41 AM IST
Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by Dec. 1.
Covid-19 vaccine updates: Bharat Biotech to recruit volunteers for trial, Pfizer files for emergency use authorisation
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON NOV 21, 2020 08:13 AM IST
Britain’s AstraZeneca has launched phase three trials of an antibody combination drug, called AZD7442, that it hopes could be used to protect those at risk of contracting the coronavirus disease for up to 12 months.
Gold gains on stimulus bets, concerns over vaccine rollout
By Reuters | Posted by Deepali Sharma | Reuters
UPDATED ON NOV 12, 2020 09:32 PM IST
Gold prices are still down about 4.1% so far this week after Monday’s encouraging late-stage vaccine trial data from Pfizer Inc powered a surge in equities and drove a sharp retreat in safe-haven bullion.
Study says misinformation could prompt people to turn against Covid-19 vaccines
By Reuters | Posted by Deepali Sharma | London
PUBLISHED ON NOV 12, 2020 09:31 PM IST
Women were more likely than men to refuse a Covid-19 vaccine, but more respondents said they would accept a vaccine if it meant protecting family, friends, or at-risk groups.
Behind Covid vaccine, a couple with shared passion for cancer research
By Reuters | Reuters
UPDATED ON NOV 10, 2020 05:24 AM IST
Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing Covid-19 based on initial data from a large study.
Pfizer says no Covid-19 vaccine data yet, could be week or more before it reports
By Reuters | Posted by Arpan Rai
PUBLISHED ON OCT 27, 2020 10:15 PM IST
Chief Executive Albert Bourla said after it has enough data for the analysis, it typically takes 5 to 7 days before the company can publicly release the data, meaning it is likely to happen after the election.
Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan
By Reuters | Posted by Karan Manral | Tokyo
UPDATED ON OCT 20, 2020 01:22 PM IST
In a statement, the firms said the study will recruit 160 people aged from 20 to 85. Earlier, they had agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine, called mRNA, in the first half of 2021.
Lonza confident of 2020 target for Moderna Covid-19 vaccine supply
By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 30, 2020 09:17 AM IST
New production lines at Lonza’s site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps - to supply 300 million vaccine doses annually - should begin delivering by December.
World Bank seeks board approval for $12 billion coronavirus vaccine financing plan
By Reuters| Posted by Susmita Pakrasi | Washington
PUBLISHED ON SEP 30, 2020 06:20 AM IST
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies.
Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers
By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 13, 2020 10:04 AM IST
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
Covid-19 vaccine developers plan pledge, Russian shot ‘passes early trial test’: All you need to know
By hindustantimes.com | Edited by Arpan Rai | Hindustan Times, New Delhi
UPDATED ON SEP 05, 2020 09:30 AM IST
Coronavirus disease outbreak has killed nearly 870,000 people and infected more than 26 million others worldwide as well as upended hundreds of millions of lives and wreaked havoc on the global economy.
